top of page

Daxotel Concentrate for Solution for Infusion 20mg/ml

Product details

Registration number: SIN15109P

Classification: Prescription Only

Active ingredients: Docetaxel Anhydrous

Strength: 20.0mg/ml

Dosage form: INJECTION, SOLUTION, CONCENTRATE

Route: INTRAVENOUS

Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD

ATC code: L01CD02

HSA approval date: 26 October 2016

Manufacturer(s): Fresenius Kabi Oncology Limited

Manufacturing country/countries: INDIA

What are the HSA registration number and classification for Daxotel Concentrate for Solution for Infusion 20mg/ml?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN15109P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for Daxotel Concentrate for Solution for Infusion 20mg/ml?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Docetaxel Anhydrous

Strength: 20.0mg/ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for Daxotel Concentrate for Solution for Infusion 20mg/ml?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SOLUTION, CONCENTRATE

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for Daxotel Concentrate for Solution for Infusion 20mg/ml?

According to the HSA dataset updated 7 August 2026:

Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD

Source for this answer

Which manufacturers and countries are listed for Daxotel Concentrate for Solution for Infusion 20mg/ml?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Fresenius Kabi Oncology Limited

Manufacturing country/countries: INDIA

Source for this answer

Where can I look up Daxotel Concentrate for Solution for Infusion 20mg/ml in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN15109P or the exact product name Daxotel Concentrate for Solution for Infusion 20mg/ml. The general register link does not preselect this product.

Source for this answer

What are the source dates for this Daxotel Concentrate for Solution for Infusion 20mg/ml record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this Daxotel Concentrate for Solution for Infusion 20mg/ml record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN15109P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page